YOLFTbeta
70

Pharmaniaga Bhd

7081 · KLSE · Healthcare / Medical Distribution

0.775MYR+0.03 (+3.33%)

Price History

Full chart

Market Stats

Previous Close0.75
Open0.77
Day Range0.755 – 0.79
52-Week Range0.995 – 1.68
Volume4.44M
Market Cap1.31B
P/E (TTM)10.00
Forward P/E9.15
EPS0.10
Dividend Yield1.92%
Beta0.67
50-Day Avg1.15
200-Day Avg1.27

About

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines; supply and installation of medical and hospital equipment; and research and development of pharmaceutical products. The company also produces and distributes food supplements. In addition, it distributes and trades diagnostic products; and develops OLIN digital platform, an integrated digital platform for ordering, inventory, billing, and sales operations. Further, the company provides logistics services and primary care products for acute diseases and specialty care products for serious and chronic diseases. Pharmaniaga Berhad was founded in 1994 and is based in Shah Alam, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOZulkifli Bin Jafar
  • Employees3.50K
  • HeadquartersNo. 7, Lorong Keluli 1B, Shah Alam, Malaysia, 40000, Malaysia
  • Websitehttps://www.pharmaniaga.com

Leadership

  • Zulkifli Bin JafarDeputy CEO, Managing Director & Director · b. 1972
  • Ms. Norai'ni Binti Mohamed AliChief Financial Officer · b. 1967
  • Dr. Badarulhisam Abdul RahmanChief Scientific Officer · b. 1968
  • Mr. Zulhazri bin RazaliHead of Market Expansion Services · b. 1967
  • Dr. Imam Fathorrahman M.M.Head of Indonesia Operations · b. 1964
  • Ms. Wan Intan Idura Wan IsmailChief Governance Officer & Company Secretary · b. 1981
  • Mr. Ahmad Shahredzuan Bin Mohd ShariffChief Operating Officer · b. 1983
  • Mr. Raja Ahmad Hidzir Bin Raja MuhamadHead of Human Resources & Administration · b. 1972
  • Mr. Mohd Izwan IshakHead of Manufacturing · b. 1979
  • Ms. Fazleena JasinHead of Sustainability

Financials

Income Statement

Currency: MYR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.81B1.95B2.12B2.19B2.19B2.32B2.38B2.82B2.73B4.82B3.48B3.40B3.76B3.93B
Growth (%)-+7.45%+9.04%+3.11%+0.00%+6.16%+2.62%+18.26%-3.38%+76.69%-27.71%-2.20%+10.43%+4.48%
Cost of Revenue1.52B1.65B1.77B1.84B1.85B1.99B2.06B2.48B2.43B4.18B3.69B3.10B3.22B3.52B
Gross Profit293.00M298.00M349.00M353.00M343.25M335.16M322.11M341.30M295.20M630.01M-209.59M307.82M540.49M409.16M
Gross Margin16.17%15.31%16.44%16.13%15.68%14.42%13.51%12.10%10.83%13.08%-6.02%9.04%14.38%10.42%
Operating Expense176.00M190.00M209.00M226.00M238.56M234.05M216.72M248.22M225.70M319.69M310.74M307.13M262.49M279.51M
Operating Income117.00M108.00M140.00M127.00M104.68M101.11M105.39M93.08M69.50M310.33M-520.33M694.00K278.01M129.65M
Operating Margin6.46%5.55%6.59%5.80%4.78%4.35%4.42%3.30%2.55%6.45%-14.95%0.02%7.39%3.30%
EBITDA-----101.84M106.29M124.19M94.43M335.28M-542.93M22.45M288.49M168.94M
EBITDA Margin-----4.38%4.46%4.40%3.47%6.96%-15.60%0.66%7.67%4.30%
Net Income62.00M55.00M94.00M84.00M45.60M53.82M42.47M-149.22M27.49M172.15M-629.92M-80.16M131.82M48.51M
Net Income Margin3.42%2.82%4.43%3.84%2.08%2.32%1.78%-5.29%1.01%3.58%-18.10%-2.35%3.51%1.24%
R&D-------11.85M7.95M5.21M10.23M5.25M8.63M4.51M
R&D as % of Total Revenue-------0.42%0.29%0.11%0.29%0.15%0.23%0.11%
Interest Expense00000036.07M40.26M33.70M33.32M40.04M61.84M71.97M61.34M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%1.51%1.43%1.24%0.69%1.15%1.82%1.91%1.56%

Balance Sheet

Currency: MYR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.22B1.11B1.24B1.50B1.68B1.61B1.91B1.59B1.58B2.26B1.85B1.91B1.99B2.25B
Total Liabilities735.00M608.00M691.00M936.00M1.15B1.08B1.40B1.25B1.24B1.79B2.20B2.19B2.14B1.79B
Total Equity---529.41M530.63M528.05M509.34M337.85M337.53M450.46M-369.69M-299.07M-171.28M434.47M
Cash35.00M33.00M32.00M23.00M70.46M27.89M22.53M17.45M22.56M52.36M52.85M114.74M126.28M110.59M
Total Debt----248.00K284.55M392.37M417.06M439.76M856.86M1.17B1.19B1.19B820.03M
Net Debt-----416.42M606.61M535.03M628.14M804.50M1.12B1.06B1.04B709.44M

Cash Flow

Currency: MYR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow17.00M255.00M213.00M7.00M35.44M239.41M-81.83M189.76M-25.71M-64.06M-142.34M46.95M42.67M-17.69M
Investing Cash Flow-127.00M-84.00M-155.00M-119.00M-146.18M-62.42M-76.59M-72.68M-32.64M-45.56M-72.33M-67.93M-45.62M-180.24M
Financing Cash Flow89.00M-171.00M-60.00M101.00M157.40M-216.75M161.86M-125.28M71.49M120.74M220.79M95.27M22.10M164.62M
Capital Expenditure23.00M44.00M31.00M61.00M43.64M29.43M17.74M20.38M32.64M45.36M77.64M73.66M31.16M29.78M
Free Cash Flow-----160.82M-153.69M169.39M-58.35M-109.41M-219.97M-26.71M11.51M-47.47M
Dividends Paid---90.61M51.82M41.54M39.00M40.40M26.14M58.95M82.53M7.86M0-
FCF to OCF-----67.17%187.80%89.26%226.94%170.81%154.54%-56.89%26.97%268.36%
Dividend Paid to FCF-----25.83%-25.38%23.85%-44.80%-53.87%-37.52%-29.42%0.00%-

Earnings

Report DateSep 30, 2003Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Dec 31, 2006Apr 8, 2011Aug 22, 2011Nov 30, 2011Feb 28, 2012Apr 6, 2012Aug 27, 2012Nov 28, 2012Feb 26, 2013Apr 5, 2013Aug 26, 2013Nov 27, 2013Feb 25, 2014Apr 4, 2014Aug 25, 2014Dec 3, 2014Feb 25, 2015Apr 3, 2015Aug 24, 2015Dec 2, 2015Feb 15, 2016May 13, 2016Aug 3, 2016Nov 1, 2016Feb 20, 2017May 16, 2017Aug 16, 2017Nov 15, 2017Feb 27, 2018May 16, 2018Aug 17, 2018Nov 21, 2018Feb 26, 2019May 15, 2019Aug 16, 2019Nov 25, 2019Mar 3, 2020May 13, 2020Aug 19, 2020Nov 19, 2020Mar 17, 2021May 21, 2021Aug 20, 2021Nov 19, 2021Feb 17, 2022May 20, 2022Aug 19, 2022Nov 24, 2022Feb 15, 2023May 18, 2023Aug 11, 2023Nov 29, 2023Feb 28, 2024May 27, 2024Aug 21, 2024Nov 26, 2024Feb 28, 2025May 16, 2025Aug 19, 2025Nov 24, 2025Feb 26, 2026May 18, 2026Aug 14, 2026
EPS Estimate---------------------------------------------------------------------------
EPS Actual0.030.020.030.030.030.030.030.020.020.000.010.01-0.010.040.030.020.020.070.040.06-0.020.060.010.010.050.060.040.030.080.070.040.050.040.040.030.03-0.000.040.020.010.050.040.010.030.010.040.020.00-0.410.050.020.00-0.010.050.030.110.190.060.000.01-0.490.000.00-0.04-0.020.020.000.070.000.060.000.000.000.020.01
Surprise---------------------------------------------------------------------------
Timing----------------------------------------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-market-Pre-marketPre-marketPre-market--

Key Statistics & Ratios

Market Cap1.31B
Enterprise Value2.04B
Trailing P/E10.00
Forward P/E9.15
Price / Sales0.31
Price / Book3.09
EPS0.10
Book Value0.35
Revenue (TTM)4.17B
Gross Profit (TTM)422.82M
EBITDA147.41M
Profit Margin1.41%
Operating Margin2.51%
Return on Equity33.70%
Return on Assets3.41%
Shares Outstanding1.31B
Shares Float505.14M
Beta0.67
Dividend Yield1.92%
Dividend Rate0.02
Payout Ratio45.05%

Dividends

20262×
0.00Sep 14, 20260.01Jun 5, 2026
20224×
0.02Dec 8, 20220.01Sep 9, 20220.02Jun 7, 20220.15Mar 7, 2022
20214×
0.06Dec 6, 20210.04Sep 7, 20210.02Jun 4, 20210.01Mar 30, 2021
20203×
0.01Dec 4, 20200.01Sep 7, 20200.04Jun 4, 2020
20193×
0.01Sep 11, 20190.04Jun 3, 20190.01Mar 8, 2019
20184×
0.03Dec 3, 20180.02Sep 3, 20180.03May 30, 20180.04Mar 13, 2018
20174×
0.03Nov 29, 20170.02Aug 29, 20170.02May 29, 20170.02Mar 7, 2017

Stock Splits

  • Jun 8, 20261:5
  • Jul 1, 2025799:475
  • Jul 5, 20215:1
  • May 31, 2013196106:89139
  • Feb 15, 201298163:89239
  • Dec 19, 20022:1